Remeditex Ventures Llc Insider Trades

Insider Trading History

Track insider trading activity for Remeditex Ventures Llc. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Soliton
Soliton SOLY
10% owner
Holding Value $0 0 shares
Last Trade
Dec 16, 2021 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$3.86M 170,808 shares
$22.58
$22.58
Apollo Endosurgery
Apollo Endosurgery APEN
10% owner
Holding Value $13.1M 1,309,392 shares
Last Trade
Dec 29, 2019 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$3.74M 1,309,392 shares
$2.86
$10.00
VYNE Therapeutics
VYNE Therapeutics VYNE
10% owner
Holding Value $0 0 shares
Last Trade
Jan 29, 2018 Sale (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$106M 3,179,843 shares
$33.39
$0.67
VYNE Therapeutics
VYNE Therapeutics VYNE
10% owner
Holding Value $1.05M 1,585,504 shares
Last Trade
Jan 29, 2018 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$88.5k 2,650 shares
$33.39
$0.67
VYNE Therapeutics
VYNE Therapeutics VYNE
10% owner
Holding Value $1.05M 1,582,854 shares
Last Trade
Jan 25, 2018 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$2.87M 100,000 shares
$28.71
$0.67
VYNE Therapeutics
VYNE Therapeutics VYNE
10% owner
Holding Value $986k 1,482,854 shares
Last Trade
Jan 24, 2018 Sale
No data
No data
$0.67
Bellicum Pharmaceuticals
Bellicum Pharmaceuticals BLCM
Director
Holding Value $114k 1,518,741 shares
Last Trade
Dec 23, 2014 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$30.5M 159,444 shares
$191.20
$0.07
Bellicum Pharmaceuticals
Bellicum Pharmaceuticals BLCM
Director
Holding Value $102k 1,359,297 shares
Last Trade
Dec 23, 2014 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$260M 1,359,297 shares
$191.20
$0.07
Bellicum Pharmaceuticals
Bellicum Pharmaceuticals BLCM
Director
Holding Value $0 0 shares
Last Trade
Dec 23, 2014 Sale (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$79.7M 417,009 shares
$191.20
$0.07
Bellicum Pharmaceuticals
Bellicum Pharmaceuticals BLCM
Director
Holding Value $132k 1,764,040 shares
Last Trade
Dec 23, 2014 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$46.9M 245,299 shares
$191.20
$0.07
Bellicum Pharmaceuticals
Bellicum Pharmaceuticals BLCM
Director
Holding Value $135k 1,807,603 shares
Last Trade
Dec 23, 2014 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$8.33M 43,563 shares
$191.20
$0.07
Bellicum Pharmaceuticals
Bellicum Pharmaceuticals BLCM
Director
Holding Value $0 0 shares
Last Trade
Dec 17, 2014 Sale
No data
No data
$0.07
Bellicum Pharmaceuticals
Bellicum Pharmaceuticals BLCM
Director
Holding Value $11.9k 159,444 shares
Last Trade
Dec 17, 2014 Purchase (In The Money)Reported as In The Money on SEC Form 4.
No data
No data
$0.07
Bellicum Pharmaceuticals
Bellicum Pharmaceuticals BLCM
Director
Holding Value $0 0 shares
Last Trade
Dec 17, 2014 Sale (In The Money)Reported as In The Money on SEC Form 4.
No data
No data
$0.07

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up